复星医药(02196.HK)控股子公司279.96亿印度卢比出售Gland Pharma约6.00%股权

智通财经09-06

【复星医药(02196.HK)控股子公司279.96亿印度卢比出售Gland Pharma约6.00%股权】智通财经APP讯，复星医药(02196.HK)发布公告，印度时间2026年9月4日，控股子公司复星医药新加坡公司通过大宗交易及集中竞价方式出售共计989.70万股Gland Pharma股份(约占截至2026年9月3日Gland Pharma股份总数的6.00%)，交易总对价(扣除交易佣金及税费前)为279.96亿印度卢比(折合约2.94亿美元1),均价(扣除交易佣金及税费前)约为2828.78印度卢比/股、较前一交易日收盘价格(即2907.90印度卢比)折让约2.72%。预计本次交易的股份过户时间为印度时间2026年9月7日。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2665645053?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-09-06 18:30","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2665645053","market":"hk","top_or_hot":-1,"title":"复星医药(02196.HK)控股子公司279.96亿印度卢比出售Gland Pharma约6.00%股权","media":"智通财经","content":"<html><body><div>\n<div>\n<b>【复星医药(02196.HK)控股子公司279.96亿印度卢比出售Gland Pharma约6.00%股权】</b>智通财经APP讯，复星医药(02196.HK)发布公告，印度时间2026年9月4日，控股子公司复星医药新加坡公司通过大宗交易及集中竞价方式出售共计989.70万股Gland \n\nPharma股份(约占截至2026年9月3日Gland \n\nPharma股份总数的6.00%)，交易总对价(扣除交易佣金及税费前)为279.96亿印度卢比(折合约2.94亿美元1),均价(扣除交易佣金及税费前)约为2828.78印度卢比/股、较前一交易日收盘价格(即2907.90印度卢比)折让约2.72%。预计本次交易的股份过户时间为印度时间2026年9月7日。                </div>\n</div></body></html>","source":"live_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药(02196.HK)控股子公司279.96亿印度卢比出售Gland Pharma约6.00%股权</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药(02196.HK)控股子公司279.96亿印度卢比出售Gland Pharma约6.00%股权\n</h2>\n\n<h4 class=\"meta\">\n\n</h4>\n\n</header>\n<article>\n<html><body><div>\n<div>\n<b>【复星医药(02196.HK)控股子公司279.96亿印度卢比出售Gland Pharma约6.00%股权】</b>智通财经APP讯，复星医药(02196.HK)发布公告，印度时间2026年9月4日，控股子公司复星医药新加坡公司通过大宗交易及集中竞价方式出售共计989.70万股Gland \n\nPharma股份(约占截至2026年9月3日Gland \n\nPharma股份总数的6.00%)，交易总对价(扣除交易佣金及税费前)为279.96亿印度卢比(折合约2.94亿美元1),均价(扣除交易佣金及税费前)约为2828.78印度卢比/股、较前一交易日收盘价格(即2907.90印度卢比)折让约2.72%。预计本次交易的股份过户时间为印度时间2026年9月7日。                </div>\n</div></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.zhitongcaijing.com/immediately.html?type=ganggu\">智通财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"复星医药","start_time":0,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","article_id":"2665645053","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2665645053","pubTimestamp":1788690653,"columns":[],"sourceInfo":{"source_id":"live_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【复星医药(02196.HK)控股子公司279.96亿印度卢比出售Gland Pharma约6.00%股权】智通财经APP讯，复星医药(02196.HK)发布公告，印度时间2026年9月4日，控股子公","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02196":"复星医药","BK1515":"抗疫概念","BK1593":"医美概念股","BK1191":"制药"},"translate_title":"Fosun Pharma (02196.HK) subsidiary sells approximately 6.00% stake in Gland Pharma for 27.996 billion Indian rupees","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02196":1.5},"content_text":"【复星医药(02196.HK)控股子公司279.96亿印度卢比出售Gland Pharma约6.00%股权】智通财经APP讯，复星医药(02196.HK)发布公告，印度时间2026年9月4日，控股子公司复星医药新加坡公司通过大宗交易及集中竞价方式出售共计989.70万股Gland \n\nPharma股份(约占截至2026年9月3日Gland \n\nPharma股份总数的6.00%)，交易总对价(扣除交易佣金及税费前)为279.96亿印度卢比(折合约2.94亿美元1),均价(扣除交易佣金及税费前)约为2828.78印度卢比/股、较前一交易日收盘价格(即2907.90印度卢比)折让约2.72%。预计本次交易的股份过户时间为印度时间2026年9月7日。","kind":"live","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2665645053","isCrawlerRequest":true}